Abstract | OBJECTIVE: STUDY DESIGN: In this double-blind, randomized, longitudinal investigation, each of 30 patients with burning mouth syndrome was assigned to one of 3 management modalities. Those in group A received an oral rinse solution of benzydamine hydrochloride 0.15% 3 times a day for 4 weeks, those in group B received a placebo 3 times a day for 4 weeks, and those in group C did not receive any kind of treatment. A visual analog scale was used for evaluation of the symptoms; a Kruskal-Wallis analysis of variance exact test was performed on the resulting data. RESULTS: The findings of this investigation failed to reveal significant differences among the groups. CONCLUSIONS:
|
Authors | A Sardella, D Uglietti, F Demarosi, G Lodi, C Bez, A Carrassi |
Journal | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
(Oral Surg Oral Med Oral Pathol Oral Radiol Endod)
Vol. 88
Issue 6
Pg. 683-6
(Dec 1999)
ISSN: 1079-2104 [Print] United States |
PMID | 10625850
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Mouthwashes
- Benzydamine
|
Topics |
- Administration, Topical
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents
(adverse effects, therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects, therapeutic use)
- Benzydamine
(adverse effects, therapeutic use)
- Burning Mouth Syndrome
(diagnosis, drug therapy)
- Chronic Disease
- Double-Blind Method
- Female
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Mouthwashes
(adverse effects, therapeutic use)
- Treatment Failure
|